THE TOP NEWS IN MARIJUANA LAW REFORM — Volume 26, Issue 11
NORML Denver Legal Seminar
 
NORML News of the Week
 

THE TOP NEWS IN MARIJUANA LAW REFORM

Volume 26   •   Issue 11   •   March 09, 2023

Study: Cannabis Products Improve Health-Related Quality of Life in Patients with Chronic Illnesses

Study: Cannabis Products Improve Health-Related Quality of Life in Patients with Chronic Illnesses

Cannabis treatment improved sleep- and anxiety-specific symptoms for up to 12 months in patients with chronic illness.

 
Justice Department Appealing Federal Ruling That Struck Down Gun Ban for Cannabis Consumers

Justice Department Appealing Federal Ruling That Struck Down Gun Ban for Cannabis Consumers

A federal judge previously ruled the federal ban unconstitutional, finding, "The use of marijuana is not in and of itself a violent, forceful, or threatening act."

 
 

LATEST NEWS

 
 
Adult-Use Marijuana Legalization Legislation Advances in Three States

Adult-Use Marijuana Legalization Legislation Advances in Three States

Legislation seeking to legalize the use of marijuana by adults advances in Delaware, Hawaii, and Minnesota.

 
 

ACTION ALERTS

 
 
Analysis: Black and Hispanic Patients Disproportionately Screened for Perinatal Cannabis Use

Analysis: Black and Hispanic Patients Disproportionately Screened for Perinatal Cannabis Use

Hispanic patients were twice as likely to be mandated to undergo testing and Black patients were four times as likely to be ordered to do so.

 
 

NORML IN THE MEDIA

 
 

NORML's mission is supported by thousands of people across America as we work to reform marijuana laws in all 50 states and at the federal level.

 

Can you chip in just $5, $10 or $20 to help us keep up the fight?

 
NORML and The NORML Foundation
1420 K Street, NW, Suite 350
Washington, DC xxxxxx

(202) 483-5500[email protected]
Facebook Twitter Instagram YouTube LinkedIn
Marijuana policy should be evidence-based.
Dispel the myths with the NORML Fact Sheets.

Too many emails? Update your subscription preferences or unsubscribe at the link below.